Caris Launches World's First ChromoSeq for Myeloid Malignancies
Caris Life Sciences launches ChromoSeq, the world’s first whole genome and transcriptome assay for myeloid malignancies, offering deeper insights and faster diagnosis.
Whole Genome Sequencing | 06/04/2026 | By News Bureau
Azenta Receives Regulatory Approval for Clinical Long-Read WGS Test
Performed within GENEWIZ from Azenta Life Sciences' CLIA-certified and CAP-accredited state-of-the-art clinical genomics laboratory, the test enables precise detection of a range of complex genomic alterations that are features of many rare diseases and undetectable by traditional approaches.
Whole Genome Sequencing | 15/11/2024 | By Aishwarya | 307
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy